bromocriptine has been researched along with spironolactone in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (50.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Caine, M | 1 |
| Marchesini, G; Pisi, E | 1 |
| Hauri, D; Schoenenberger, A | 1 |
| Costa, C; De Pedrini, P; Suraci, C | 1 |
| Shangold, MM | 1 |
| Blum, I; Chovers, I; Kaufman, H; Marilus, R; Rusecki, Y | 1 |
| Blum, I; Bruhis, S; Kaufman, H | 1 |
| Johnson, SR | 1 |
| Schröder, S; Strobel, J | 1 |
4 review(s) available for bromocriptine and spironolactone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Conservative treatment of benign prostatic hyperplasia (author's transl)].
Topics: Adrenergic alpha-Antagonists; Bromocriptine; Cyproterone; Gestonorone Caproate; Humans; Male; Medrogestone; Megestrol; Plant Extracts; Polyenes; Prostatic Hyperplasia; Spironolactone; Tamoxifen | 1982 |
Drug therapy for the premenstrual syndrome.
Topics: Bromocriptine; Female; Humans; Premenstrual Syndrome; Progesterone; Pyridoxine; Spironolactone; Syndrome | 1983 |
Premenstrual syndrome therapy.
Topics: Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Bromocriptine; Contraceptives, Oral, Combined; Danazol; Evidence-Based Medicine; Exercise Therapy; Fatty Acids, Essential; Female; gamma-Linolenic Acid; Gonadotropin-Releasing Hormone; Humans; Linoleic Acids; Oenothera biennis; Ovariectomy; Plant Oils; Premenstrual Syndrome; Progesterone; Progestins; Pyridoxine; Selective Serotonin Reuptake Inhibitors; Spironolactone; Vitamin E | 1998 |
10 other study(ies) available for bromocriptine and spironolactone
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Medical management of prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Aged; Aging; Bromocriptine; Cyproterone; Humans; Male; Phenoxybenzamine; Progestins; Prostate; Prostatic Hyperplasia; Spironolactone | 1986 |
[Hepatic coma. Therapeutic aspects].
Topics: Amino Acids; Bromocriptine; Electrolytes; Furosemide; Glucose; Hepatic Encephalopathy; Histamine H2 Antagonists; Humans; Infusions, Parenteral; Levodopa; Nitrogen; Spironolactone; Vitamin B Complex | 1984 |
[Therapy of female hirsutism: current status and new findings].
Topics: Adrenal Cortex Hormones; Adrenal Hyperplasia, Congenital; Androgen Antagonists; Androgens; Bromocriptine; Cimetidine; Cyproterone; Cyproterone Acetate; Drug Combinations; Estradiol Congeners; Female; Hirsutism; Humans; Polycystic Ovary Syndrome; Progesterone Congeners; Spironolactone; Thyronines; Time Factors | 1983 |
Successful treatment of polycystic ovary syndrome with spironolactone or bromocriptine.
Topics: Adult; Bromocriptine; Female; Hirsutism; Hormones; Humans; Hypertension; Polycystic Ovary Syndrome; Spironolactone | 1981 |
Clinical evaluation of the effects of combined treatment with bromocriptine and spironolactone in two women with the polycystic ovary syndrome.
Topics: Adult; Blood Pressure; Body Weight; Bromocriptine; Drug Therapy, Combination; Female; Glucose Tolerance Test; Hirsutism; Humans; Luteinizing Hormone; Polycystic Ovary Syndrome; Spironolactone | 1981 |
[Postpartum cardiomyopathy].
Topics: Adrenergic beta-1 Receptor Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Antihypertensive Agents; Bisoprolol; Bromocriptine; Cardiomyopathies; Female; Heparin, Low-Molecular-Weight; Humans; Mineralocorticoid Receptor Antagonists; Postpartum Period; Radiography; Ramipril; Risk Factors; Spironolactone; Sulfonamides; Torsemide; Treatment Outcome | 2011 |